These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 22821790)
1. Effect of a pharmacist intervention in Spanish community pharmacies on blood pressure control in hypertensive patients. Fikri-Benbrahim N; Faus MJ; Martínez-Martínez F; Alsina DG; Sabater-Hernández D Am J Health Syst Pharm; 2012 Aug; 69(15):1311-8. PubMed ID: 22821790 [TBL] [Abstract][Full Text] [Related]
2. A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program. Magid DJ; Olson KL; Billups SJ; Wagner NM; Lyons EE; Kroner BA Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):157-63. PubMed ID: 23463811 [TBL] [Abstract][Full Text] [Related]
3. Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION). Tsuyuki RT; Houle SK; Charrois TL; Kolber MR; Rosenthal MM; Lewanczuk R; Campbell NR; Cooney D; McAlister FA; Circulation; 2015 Jul; 132(2):93-100. PubMed ID: 26063762 [TBL] [Abstract][Full Text] [Related]
4. Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study). Zillich AJ; Sutherland JM; Kumbera PA; Carter BL J Gen Intern Med; 2005 Dec; 20(12):1091-6. PubMed ID: 16423096 [TBL] [Abstract][Full Text] [Related]
5. Pharmacist-Directed Self-Management of Blood Pressure Versus Conventional Management in Patients with Hypertension: A Randomized Control Trial. Khiali S; Khezerlo-Aghdam N; Namdar H; Entezari-Maleki T High Blood Press Cardiovasc Prev; 2021 May; 28(3):283-290. PubMed ID: 33765257 [TBL] [Abstract][Full Text] [Related]
6. Success in the Achieving CARdiovascular Excellence in Colorado (A CARE) Home Blood Pressure Monitoring Program: A Report from the Shared Networks of Colorado Ambulatory Practices and Partners (SNOCAP). DeAlleaume L; Parnes B; Zittleman L; Sutter C; Chavez R; Bernstein J; LeBlanc W; Dickinson M; Westfall JM J Am Board Fam Med; 2015; 28(5):548-55. PubMed ID: 26355126 [TBL] [Abstract][Full Text] [Related]
7. Effects of lifestyle advice provided by pharmacists on blood pressure: The COMmunity Pharmacists ASSist for Blood Pressure (COMPASS-BP) randomized trial. Okada H; Onda M; Shoji M; Sakane N; Nakagawa Y; Sozu T; Kitajima Y; Tsuyuki RT; Nakayama T Biosci Trends; 2018 Jan; 11(6):632-639. PubMed ID: 29249774 [TBL] [Abstract][Full Text] [Related]
8. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients. Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974 [TBL] [Abstract][Full Text] [Related]
9. Impact of a community pharmacists' hypertension-care service on medication adherence. The AFenPA study. Fikri-Benbrahim N; Faus MJ; Martínez-Martínez F; Sabater-Hernández D Res Social Adm Pharm; 2013; 9(6):797-805. PubMed ID: 23391845 [TBL] [Abstract][Full Text] [Related]
10. A multimodal blood pressure control intervention in 3 healthcare systems. Magid DJ; Ho PM; Olson KL; Brand DW; Welch LK; Snow KE; Lambert-Kerzner AC; Plomondon ME; Havranek EP Am J Manag Care; 2011 Apr; 17(4):e96-103. PubMed ID: 21774100 [TBL] [Abstract][Full Text] [Related]
11. A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring. Lacourcière Y; Neutel JM; Davidai G; Koval S Am J Hypertens; 2006 Jan; 19(1):104-12. PubMed ID: 16461201 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). McLean DL; McAlister FA; Johnson JA; King KM; Makowsky MJ; Jones CA; Tsuyuki RT; Arch Intern Med; 2008 Nov; 168(21):2355-61. PubMed ID: 19029501 [TBL] [Abstract][Full Text] [Related]
13. Development and implementation of blood pressure screening and referral guidelines for German community pharmacists. Schulz M; Griese-Mammen N; Schumacher PM; Strauch D; Freudewald L; Said A; Tsuyuki RT; Laufs U; Kintscher U; Böhm M; Mahfoud F J Clin Hypertens (Greenwich); 2020 Oct; 22(10):1807-1816. PubMed ID: 32864864 [TBL] [Abstract][Full Text] [Related]
14. Magnitude of the white-coat effect in the community pharmacy setting: the MEPAFAR study. Sabater-Hernández D; de la Sierra A; Sánchez-Villegas P; Baena MI; Amariles P; Faus MJ; Am J Hypertens; 2011 Aug; 24(8):887-92. PubMed ID: 21509052 [TBL] [Abstract][Full Text] [Related]
15. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study. Shimada K; Ogihara T; Saruta T; Kuramoto K; Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495 [TBL] [Abstract][Full Text] [Related]
16. Personalized Hypertension Management Using Patient-Generated Health Data Integrated With Electronic Health Records (EMPOWER-H): Six-Month Pre-Post Study. Lv N; Xiao L; Simmons ML; Rosas LG; Chan A; Entwistle M J Med Internet Res; 2017 Sep; 19(9):e311. PubMed ID: 28928111 [TBL] [Abstract][Full Text] [Related]
17. Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. Green BB; Cook AJ; Ralston JD; Fishman PA; Catz SL; Carlson J; Carrell D; Tyll L; Larson EB; Thompson RS JAMA; 2008 Jun; 299(24):2857-67. PubMed ID: 18577730 [TBL] [Abstract][Full Text] [Related]
18. Implementation of adherence support for patients with hypertension despite antihypertensive therapy in general practice: a cluster randomized trial. van de Steeg-van Gompel CH; Wensing M; De Smet PA Am J Hypertens; 2010 Sep; 23(9):1038-45. PubMed ID: 20360753 [TBL] [Abstract][Full Text] [Related]
19. Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials. Lacourcière Y; Neutel JM; Schumacher H Clin Ther; 2005 Nov; 27(11):1795-805. PubMed ID: 16368450 [TBL] [Abstract][Full Text] [Related]
20. 24 hour ambulatory blood pressure values corresponding to office blood pressure value of 130/80 mm Hg. Rihacek I; Frana P; Plachy M; Kianicka B; Soucek M; Vasku A Kardiol Pol; 2013; 71(7):675-80. PubMed ID: 23907899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]